Filgrastim, kan hücrelerinin çoğalmasını ve farklılaşmasını sağlayan bir hematopoietik büyüme faktörüdür. Spontan dalak rüptürü ve kapiller kaçış sendromu, filgrastim tedavisinin ciddi yan etkilerindendir. Patlama yaralanması sonrası yoğun bakımda ezilme hasarı (Crush sendromu) ve sepsis tanılarıyla izlenen ve beyaz kan hücresi sayısında düşme nedeni ile filgrastim uygulanan hastada gözlenen kapiller kaçış sendromu ve spontan dalak rüptürü komplikasyonlarına yaklaşım sunulmaktadır. Filgrastim, spontan dalak rüptürü ve kapiller kaçış sendromuna neden olabilir. Filgrastim kullanımında hastaların dalakları periyodik olarak kontrol edilmelidir.
Anahtar Kelimeler: Filgrastim; kapiller kaçış sendromu; spontan dalak rüptürü
Filgrastim is a hematopoietic growth factor that allows blood cells to proliferate and differentiate. Spontaneous splenic rupture and capillary leak syndrome are serious side effects of filgrastim therapy. The patient was followed up in the intensive care unit after burst injury with Crush syndrome and sepsis. Filgrastim was applied due to a decrease in the white blood cell count. The patient's approach to capillary leak syndrome and spontaneous splenic rupture complications is presented. Filgrastim can cause spontaneous splenic rupture and capillary leak syndrome. Splenic should be checked periodically during the use of filgrastim.
Keywords: Filgrastim; capillary leak syndrome; spontaneous splenic rupture
- Sörgel F, Schwebig A, Holzmann J, Prasch S, Singh P, Kinzig M, et al. Comparability of biosimilar filgrastim with originator filgrastim: protein characterization, pharmacodynamics, and pharmacokinetics. BioDrugs. 2015;29(2):123-31. [Crossref] [PubMed] [PMC]
- Abboud CN, Lang N, Fung H, Lammerich A, Buchner A, Liu P, et al. Real-world safety experience of tevagrastim/ratiograstim/biograstim and tbo-filgrastim, short-acting recombinant human granulocyte colony-stimulating factors. Support Care Cancer. 2019;27(7):2569-77. [Crossref] [PubMed]
- Bo L, Wang F, Zhu J, Li J, Deng X. Granulocyte-colony stimulating factor (G-CSF) and granulocyte-macrophage colony stimulating factor (GM-CSF) for sepsis: a meta-analysis. Crit Care. 2011;15(1):R58. [Crossref] [PubMed] [PMC]
- Schefold JC. Immunostimulation using granulocyte- and granulocyte-macrophage colony stimulating factor in patients with severe sepsis and septic shock. Crit Care. 2011;15(2):136. [Crossref] [PubMed] [PMC]
- Mathias B, Szpila BE, Moore FA, Efron PA, Moldawer LL. A review of GM-CSF therapy in sepsis. Medicine (Baltimore). 2015;94(50):e2044. [Crossref] [PubMed] [PMC]
- Siddall E, Khatri M, Radhakrishnan J. Capillary leak syndrome: etiologies, pathophysiology, and management. Kidney Int. 2017;92(1):37-46. [Crossref] [PubMed]
- Ganetsky A, Kucharczuk C, Del Percio S, Frey N, Gill S. Spontaneous subcapsular splenic hematoma associated with filgrastim in a patient undergoing allogeneic hematopoietic stem cell transplantation. Ann Pharmacother. 2013;47(5):e22. [Crossref] [PubMed]
- Kuendgen A, Fenk R, Bruns I, Dommach M, Schutte A, Engers R, et al. Splenic rupture following administration of pegfilgrastim in a patient with multiple myeloma undergoing autologous peripheral blood stem cell transplantation. Bone Marrow Transplant. 2006;38(1):69-70. [Crossref] [PubMed]
- Akyol G, Pala C, Yildirim A, Keklika M, Demir K, Dortdudak S, et al. A rare but severe complication of filgrastim in a healthy donor: splenic rupture. Transfus Apher Sci. 2014;50(1):53-5. [Crossref] [PubMed]
- Nuamah NM, Goker H, Kilic YA, Dagmoura H, Cakmak A. Spontaneous splenic rupture in a healty allogeneic donor of perippheral-blood stem cell following the administration of granulocyte colony stimulating factor (g-csf). A case report and review of the literature. Haematologica. 2006;91(5 Suppl):ECR08. [PubMed]
- Stiff PJ, Bensinger W, Abidi MH, Gingrich R, Artz AS, Nademanee A, et al. Clinical and ultrasonic evaluation of spleen size during peripheral blood progenitor cell mobilization by filgrastim: results of an open-label trial in normal donors. Biol Blood Marrow Transplant. 2009;15(7):827-34. [Crossref] [PubMed]
- Gnanaraj J, Parnes A, Francis CW, Go RS, Takemoto CM, Hashmi SK, et al. Approach to pancytopenia: diagnostic algorithm for clinical hematologists. Blood Rev. 2018;32(5):361-7. [Crossref] [PubMed]
- De Backer D, Cecconi M, Lipman J, Machado F, Myatra SN, Ostermann M, et al. Challenges in the management of septic shock: a narrative review. Intensive Care Med. 2019;45(4):420-33. [Crossref] [PubMed]
- Singer M, Deutschman CS, Seymour CW, Shankar-Hari M, Annane D, Bauer M, et al. The third international consensus definitions for sepsis and septic shock (Sepsis-3). JAMA. 2016;23;315(8):801-10. [Crossref] [PubMed] [PMC]
- Ishikawa K, Tanaka H, Matsuoka T, Shimazu T, Yoshioka T, Sugimoto H. Recombinant human granulocyte colony-stimulating factor attenuates inflammatory responses in septic patients with neutropenia. J Trauma. 1998;44(6):1047-54. [Crossref] [PubMed]
- Wagner M, Hectors S, Bane O, Gordic S, Kennedy P, Besa C, et al. Noninvasive prediction of portal pressure with MR elastography and DCE-MRI of the liver and spleen: preliminary results. J Magn Reson Imaging. 2018;48(4):1091-103. [Crossref] [PubMed] [PMC]
- Talakić E, Schaffellner S, Kniepeiss D, Mueller H, Stauber R, Quehenberger F, et al. CT perfusion imaging of the liver and the spleen in patients with cirrhosis: is there a correlation between perfusion and portal venous hypertension? Eur Radiol. 2017;27(10):4173-80. [Crossref] [PubMed] [PMC]
- Nembhard CE, Hwabejire JO, Obirieze AC, Oyetunji TA, Cornwell EE, Greene WR, et al. Trauma associated splenic artery aneurysms: an analysis of the National Trauma Data Bank. Am J Surg. 2016;211(4):739-43. [Crossref] [PubMed]
.: Process List